AccuStem Sciences Limited (ACMSY) Stock Analysis
DELISTED 2025
What happened to AccuStem Sciences Limited (ACMSY) stock?
AccuStem Sciences Limited (ACMSY) no longer trades on public markets. It was delisted in April 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- April 2025
- Last recorded price (historical):
- $0.13 (last quote on record before the April 2025 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
AccuStem Sciences Limited (ACMSY). AccuStem Sciences Limited, incorporated in 2020 and based in London, UK, specializes in genomic signature-based assays for breast cancer prognosis.
Last analyzed: Jun 14, 2026AccuStem Sciences Limited (ACMSY) Healthcare & Pipeline Overview
ACMSY OTC Market Information
ACMSY trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ACMSY shares?
No. ACMSY stopped trading on public markets in April 2025, so the shares are not available through a broker. Anything you see quoted for ACMSY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ACMSY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to AccuStem Sciences Limited. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.